dabigatran has been researched along with Thrombosis in 187 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (4.81) | 29.6817 |
| 2010's | 146 (78.07) | 24.3611 |
| 2020's | 32 (17.11) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, MH; Ren, YJ; Wang, F | 1 |
| Ren, W; Ren, Y; Wang, S | 1 |
| Bai, T; Feng, Q; Guo, T; Jia, J; Li, X; Liu, Y; Pei, J; Song, Y; Wu, L; Wu, S; Zhang, Y; Zheng, X | 1 |
| Cui, Y; Gong, Y; Hu, K; Jiang, J; Liu, Z; Ma, L; Mu, G; Wang, Z; Xiang, Q; Xie, Q; Zhang, H; Zhou, S | 1 |
| Barnes, GD; DeCamillo, D; Haymart, B | 1 |
| Avery, P; Biss, T; Kamali, F; Kampouraki, E; Wynne, H | 1 |
| Chu, H; Du, X; Feng, M; Fu, G; He, B; Liu, J; Wang, B; Wang, Z; Yu, Y; Zhuo, W | 1 |
| Chan, H; Hanna, M; Merriman, E; Royle, G; Stone, L | 1 |
| Abe, K; Amano, H; Asaoka, Y; Honda, T; Kodashima, S; Komatsuda, S; Kozuma, K; Manabe, D; Tanaka, A; Yamamoto, H; Yamamoto, T; Yanagisawa, D | 1 |
| Davis, K; Khouli, C; Mihm, A; Nisly, SA; Sebaaly, J; Wooten, L | 1 |
| Angona, RE; Baldzizhar, A; Eaton, MP; Feng, C; Lebedko, N; Nadtochiy, SM; Stefanos, T | 1 |
| Halimeh, S; Male, C; Nowak-Goettl, U | 1 |
| Aweimer, A; Ewers, A; Muegge, A; Patsalis, PC | 1 |
| Cao, S; He, T; Wu, X; Yu, B | 1 |
| Budnik, M; Ciba-Stemplewska, A; Filipiak, KJ; Gawałko, M; Gorczyca-Głowacka, I; Jurek, A; Kapłon-Cieślicka, A; Krzesiński, P; Opolski, G; Scisło, P; Uziębło-Życzkowska, B; Wożakowska-Kapłon, B | 1 |
| Guo, R; Li, N; Sheng, R; Sun, X; Wang, J | 1 |
| Bito, A; Fujii, H; Fukuda, M; Murata, N; Narahara, Y | 1 |
| Algahim, M; Anderson, B; Angona, RE; Darrow, N; Eaton, MP; Feng, C; Jones, CCPK; LeMoine, D; Nadtochiy, SM; Stefanos, T; Swartz, MF; Westcott, R | 1 |
| Dong, J; Du, X; Ma, C; Yang, Y | 1 |
| Callejas, S; Ceron, C; Cortes-Canteli, M; Fernandez-Nueda, I; Fuster, V; Ibanez, B; Jno-Charles, OC; Kruyer, A; Marcos-Diaz, A; Norris, EH; Richards, AT; Rodriguez, I; Ruiz-Cabello, J; Sanchez-Gonzalez, J; Strickland, S | 1 |
| Fredenburgh, JC; Jaffer, IH; Stafford, A; Weitz, JI; Whitlock, RP | 1 |
| Bao, Y; Hua, W; Jin, Q; Ke, M; Lin, C; Ling, T; Pan, W; Quan, J; Wei, Y; Wu, L; Xie, Y; Zhang, N | 1 |
| Auditeau, C; Blandinières, A; Gendron, N; Smadja, DM; Talbot, A | 1 |
| Abad-Santos, F; Almenara, S; Koller, D; Mejía, G; Navares-Gómez, M; Ochoa, D; Román, M; Saiz-Rodríguez, M; Soria-Chacartegui, P; Zubiaur, P | 1 |
| Abdelmaseeh, P; Asinger, R; Megaly, M; Sedhom, R | 1 |
| Barco, S; Barosi, G; Di Pilla, M; Lodigiani, C; Sacco, C | 1 |
| Angona, RE; Baldzizhar, A; Eaton, MP; Feng, C; Jones-Smith, KL; Nadtochiy, SM; O'Leary, KE; Stefanos, T | 1 |
| Chen, W; Fu, J; Wu, T; Xia, X; Zhang, J | 1 |
| Dannenberg, L; Hohlfeld, T; Kelm, M; Orban, M; Petzold, T; Polzin, A; Thienel, M; Wolff, G; Zeus, T | 1 |
| Bernier, M; Drici, MD; Lancrerot, SL; Lavrut, T; Parassol, N; Rocher, F; Viotti, J | 1 |
| Hardy, LJ; Khan, AA; Lau, YC; Lip, GYH; Philippou, H; Shantsila, E | 1 |
| Egred, M; Farag, M; Gorog, DA; Gue, YX; Spinthakis, N | 1 |
| Chocron, R; Gendron, N; Le Beller, C; Lillo-le Louët, A; Philippe, A; Smadja, DM | 1 |
| Cuccia, C; Enea, I; Fresco, C; Paciaroni, M; Patti, G; Pecora, D; Rocca, B; Rubboli, A | 1 |
| Connor, DE; Hayward, CS; Jain, P; Jansz, P; Joseph, J; Kerr, NP; Muthiah, K; Rao, SD; Robson, D; Shehab, S | 1 |
| Birnie, DH; Connolly, SJ; Coutu, B; Douketis, J; Essebag, V; Ezekowitz, M; Healey, JS; Hohnloser, SH; Lip, GYH; Moriarty, A; Oldgren, J; Parkash, R; Proietti, R; Wang, J | 1 |
| Fink, B; Mayer, A; Schuster, P | 1 |
| Atkinson, HM; Berry, LR; Chan, AKC; Chan, HHW; Gantioqui, J; Nossair, FF | 1 |
| Bernstein, RA; Dubiel, R; Eikelboom, JW; Glund, S; Huisman, MV; Hylek, EM; Kam, CW; Kamphuisen, PW; Kreuzer, J; Levy, JH; Pollack, CV; Reilly, PA; Royle, G; Sellke, FW; Stangier, J; Steiner, T; van Ryn, J; Verhamme, P; Wang, B; Weitz, JI; Young, L | 1 |
| Fukuoka, H; Hoshida, S; Ikeoka, K; Inui, H; Minamisaka, T; Shinoda, Y; Watanabe, T | 1 |
| Arima, Y; Hokimoto, S; Ishii, M; Ito, M; Izumiya, Y; Kaikita, K; Kojima, S; Ogawa, H; Sueta, D; Takashio, S; Tsujita, K; Yamabe, H; Yamamoto, E; Yamamuro, M | 1 |
| Carley, B; Draper, E; Griesbach, S; Krueger, K; Larson, T; Parkhurst, B | 1 |
| Baldovino, S; Fenoglio, R; Radin, M; Roccatello, D; Schreiber, K; Sciascia, S | 1 |
| Baldi, M; Ciconte, G; Conti, M; Pappone, C; Saviano, M; Vicedomini, G | 1 |
| Adar, A; Cakan, F; Onalan, O | 1 |
| Ahuja, T; Cirrone, F; Green, D; Papadopoulos, J; Raco, V; Xiang, E | 1 |
| Rubboli, A | 1 |
| Gil, M; Webster, E | 1 |
| Asmar, J; Bizouard, G; Cainzos-Achirica, M; Forns, J; Hellfritzsch, M; Perez-Gutthann, S; Pladevall-Vila, M; Plana, E; Pottegård, A; Rasmussen, L; Varas-Lorenzo, C; Zint, K | 1 |
| Al-Samkari, H; Connors, JM | 1 |
| Cheung, JW; D'Amato, S; Gabriels, J; Ip, JE; Khan, M; Lerman, B; Liu, CF; Markowitz, SM; Patel, A; Shaban, N; Singh, P; Thomas, G; Wu, M | 1 |
| Gheysens, O; Goffin, KE; Hoylaerts, MF; Jacquemin, M; Liesenborghs, L; Peerlinck, K; Peetermans, M; Peetermans, WE; Vanassche, T; Verhaegen, J; Verhamme, P; Wijngaerden, EV | 1 |
| Leow, AS; Loh, JP; Sia, CH; Tan, BY | 1 |
| Arena, G; Cassese, A; Golino, P; Mosella, M; Palladino, A; Papa, AA; Rago, A | 1 |
| Fredgart, M; Gill, S | 1 |
| Bangdiwala, SI; Berwanger, O; Biccard, BM; Botto, F; Chaudhry, NK; Connolly, SJ; de Nadal, M; Devereaux, PJ; Duceppe, E; Eikelboom, JW; Erb, J; Franzosi, MG; Guyatt, G; Hoeft, A; Iglesias, PP; Kearon, C; Magloire, P; Mayosi, B; Meyhoff, CS; Neary, J; Pettit, S; Rahate, PV; Rao, M; Rao-Melacini, P; Rodseth, R; Sessler, DI; Sharma, M; Srinathan, SK; Szczeklik, W; Tandon, V; Villar, JC; Vincent, J; Xavier, D; Yusuf, S | 1 |
| Han, YL; Liang, M; Liu, NN; Wang, ZL; Xing, XF; Zhou, WW | 1 |
| Ahuja, T; Green, D; Raco, V | 1 |
| Carlsen, SM; Giannadakis, C; Gulati, AM; Gulati, S; Jakola, AS; Jensberg, H; Madsbu, MA; Salvesen, Ø; Solheim, O; Øie, LR | 1 |
| Sheikh-Taha, M | 1 |
| Chen, W; Gao, D; Gao, G; He, Y; Lakin, R; Liu, X; Sun, H; Wang, Y; Yan, M; Yang, H; Yang, P; Yu, M; Zhao, Q | 1 |
| Díaz Antón, B; Rodríguez-Roda, J; Rodriguez-Rodrigo, FJ | 1 |
| Aslan, U; Aydın, A; Dağdeviren, B; Gürol, T; Kemaloğlu Öz, T; Kobegenova, M; Sarıgül, NU; Soylu, Ö | 1 |
| Ako, J; Fukaya, T; Kimura, T; Kozuma, K; Morino, Y; Nakao, K; Okazaki, K; Okumura, K | 1 |
| Aydin Ozturk, P; Ozturk, U; Yilmaz, T | 1 |
| Akgun, FS; Caliskan, T; Kaplan, N; Karaarslan, N; Ozbek, H; Simsek, AT; Sirin, DY; Yilmaz, I | 1 |
| Fleddermann, AM; Hayes, CH; Magalski, A; Main, ML | 1 |
| Biessen, EA; Borissoff, JI; Daemen, MJ; Degen, JL; Esmon, CT; Hackeng, TM; Hamulyák, K; Heeneman, S; Leenders, P; Loubele, ST; Otten, JJ; Soehnlein, O; Spronk, HM; ten Cate, H; van Oerle, R; van Ryn, J; Weiler, H | 1 |
| Bock, F; Hartung, K; Isermann, B; Meyer, F | 1 |
| Dalmau, FG | 1 |
| Gong, GQ; He, GW; Jiang, ML; Li, YZ; Wang, XH; Xu, YG; Yang, WH; Yang, XZ; Zhou, Y | 1 |
| Kamphuisen, PW; Lisman, T; Northup, PG; Porte, RJ | 1 |
| Eby, C | 1 |
| Bordeaux, JS; Schmitt, AR; Zender, CA | 1 |
| Nagamoto, Y; Sadamatsu, K; Shiomi, T | 1 |
| Bett, N; Hamilton-Craig, C; Luis, C; Luis, SA; Poon, K; Shukla, A | 1 |
| Ajiro, Y; Iwade, K; Morita, S; Uchida, Y | 1 |
| Campos, K; Coulter, S | 1 |
| Baruch, L | 1 |
| Joutsi-Korhonen, L; Lassila, R; Pétas, A; Rannikko, AS; Säily, VM; Taari, K | 1 |
| Ansell, J; Shameem, R | 1 |
| Rosenfeld, JV; Schaerf, NB; Thomas, PA | 1 |
| Hayashida, K; Koga, Y; Matsuura, T; Mine, D; Nagamoto, Y; Okahara, A; Sadamatsu, K; Shiomi, T; Shirahama, T; Takegami, K; Yoshida, K | 1 |
| Akgüllü, C; Eryılmaz, U; Kurtoğlu, T | 1 |
| Chandler, WL | 1 |
| Fries, D; Giurea, A; Gütl, M; Halbmayer, WM; Kozek-Langenecker, S; Pachucki, A; Roithinger, F; Steinlechner, B; Thaler, H; Weltermann, A | 1 |
| Lee, CL; Tsao, HM; Wang, HH | 1 |
| Avram, MJ; Benzon, HT; Bonow, RO; Green, D | 1 |
| Esmon, CT | 1 |
| Hosokawa, K; Koide, T; Maruyama, I; Miura, N; Ohnishi, T; Sameshima, H; Tanaka, KA | 1 |
| Angiolillo, DJ; Capodanno, D | 1 |
| Fredenburgh, JC; Liao, P; Roberts, RS; Weitz, JI; Yau, JW | 1 |
| Hess, T; Konturek, P | 1 |
| Kelm, M; Nitschmann, S; Zeus, T | 1 |
| Marciniak, ET; McCurdy, MT; Reed, RM; Weiler, B | 1 |
| Carroll, VS; Frei, J | 1 |
| Eichinger, S; Gouya, G; Kapiotis, S; Kyrle, PA; Litschauer, B; Mayer, P; Smerda, L; Weisshaar, S; Wolzt, M | 1 |
| Berghold, A; Kemperdick, B; Mergenthal, K; Petersen, JJ; Rauck, S; Roehl, I; Schulz-Rothe, S; Siebenhofer, A; Ulrich, LR | 1 |
| Hassager, C; Kjaergaard, J; Saust, LT; Thomsen, JH; Wachtell, K | 1 |
| Blann, AD | 1 |
| Bruckner, T; Hess, A; Katus, HA; Kieser, M; Mereles, D; Pohlmeier, M; Scholz, E; Schweizer, PA; Thomas, D; Zitron, E; Zylla, MM | 1 |
| Cantürk, E; Güler, E; Karaca, O; Kızılırmak, F; Omaygenç, O | 1 |
| Clark, B; Daw, H; Ghobrial, M; Haddad, A; Randhawa, J; Spiro, T; Thiruchelvam, N | 1 |
| Hirao, H; Suenari, K; Ueda, H | 1 |
| Steiner, T | 1 |
| Greinacher, A; Selleng, K; Thiele, T | 1 |
| Hao, L; Rong, B; Wang, JT; Xie, F; Yue, X; Zhang, W; Zhang, Y; Zheng, ZT; Zhong, JQ; Zhu, Q | 1 |
| Dogné, JM; Douxfils, J; Mullier, F | 1 |
| Agewall, S; Huber, K; Lip, GY; Rubboli, A | 1 |
| Bernstein, RA; Dubiel, R; Eikelboom, J; Glund, S; Huisman, MV; Hylek, EM; Kam, CW; Kamphuisen, PW; Kreuzer, J; Levy, JH; Pollack, CV; Reilly, PA; Sellke, FW; Stangier, J; Steiner, T; Verhamme, P; Wang, B; Weitz, JI | 1 |
| Breithardt, G; Deuster, O; Ferner, M; Konrad, T; Meinertz, T; Münzel, T; Rostock, T; Seibert-Grafe, M; von Bardeleben, S; Wachtlin, D | 1 |
| Amioka, M; Fujiwara, M; Kaseda, S; Ohashi, N; Okada, T; Uchida, M | 1 |
| Alonso-Coello, P; Brosa, M; Carles, M; Garcia-Alamino, JM; Guyatt, G; Souto, JC | 1 |
| Bailly, N; Baudar, J; Chatelain, B; Dincq, AS; Dogné, JM; Douxfils, J; Gourdin, M; Lessire, S; Mullier, F | 1 |
| Angelopoulou, SM; Bouziana, SD; Giampatzis, V; Hatzitolios, AI; Konstantara, F; Kostaki, S; Papadopoulou, M; Savopoulos, C; Spanou, M; Tziomalos, K | 1 |
| Afshari, F; Bösche, LI; Ewers, A; Gotzmann, M; Mügge, A; Schöne, D | 1 |
| Ardillon, L; Boon, LM; Eeckhoudt, S; Hermans, C; Lambert, C | 1 |
| Gross, PL; Ni, R; Saldanha, LJ; Shaya, SA; Vaezzadeh, N; Zhou, J | 1 |
| Crosca, S; Messina, F; Romano, P | 1 |
| Ajjan, RA; Angiolillo, DJ; Bass, TA; Bhatti, M; Cho, JR; DeGroat, C; Franchi, F; Guzman, LA; King, R; Phoenix, F; Rollini, F; Tello-Montoliu, A; Zenni, MM | 1 |
| Agewall, S; Atar, D; Drexel, H; Husted, SE; Kaski, JC; Kjeldsen, K; Koller, L; Lewis, BS; Lip, GYH; Morais, J; Niessner, A; Storey, RF; Tamargo, J; Torp-Pedersen, C; Verheugt, FWA; Wassmann, S | 1 |
| Benöhr, P; Hohmann, C; Neumann-Haefelin, T; Radziwill, R | 1 |
| Gellér, L; Merkely, B; Szegedi, N; Széplaki, G; Tahin, T | 1 |
| Albuquerque, FP; Aras, R; de Almeida Nunes, B; de Bulhões, FV; de Souza Fernandes, AM; de Souza Roriz, P; Durães, AR | 1 |
| Masuda, Y; Matsuno, K; Shimizu, C | 1 |
| Harenberg, J | 1 |
| Finsterer, J; Pommer, P; Schneider, B; Stöllberger, C | 1 |
| Dittmeier, M; Fluri, F; Kleinschnitz, C; Kraft, P; Schuhmann, MK; Wassmuth, K | 1 |
| Hart, C; Schmid, S | 1 |
| Akhtyamov, IF; Shigaev, ES; Ziatdinov, BG | 1 |
| Ataullakhanov, FI; Ayusheev, DB; Bernakevich, AI; Gribkova, IV; Lipets, EN; Ovsepyan, RA; Rekhtina, IG; Sinauridze, EI | 1 |
| Durian, MF; Janssen, AM; Szabó, B; van de Kerkhof, D; van der Voort, PH | 1 |
| Agdirlioglu, T; Borowski, M; Kellner, M; Reers, S; Reppel, M; Thiele, H; Waltenberger, J | 1 |
| Butala, NM; Kartoun, U; Kennedy, KF; Mahmood, S; Secemsky, EA; Shaw, SY; Wasfy, JH; Yeh, RW | 1 |
| Doerner, A; Friebel, J; Hassanein, A; Kränkel, N; Landmesser, U; Rauch, U; Steffens, D; Witkowski, M | 1 |
| Góralczyk, T; Malec, K; Undas, A | 1 |
| Adelmeijer, J; Bos, S; Boyett, SL; Daita, K; Lisman, T; Potze, W; Sanyal, AJ; Siddiqui, MS | 1 |
| Ding, R; Fu, Y; Gong, T; Hu, M; Zhang, J; Zhang, Z | 1 |
| Albers, L; Bolt, J; Duffy, P; Hager, N; Semchuk, W; Wojcik, W | 1 |
| Attisani, M; Baronetto, A; Boffini, M; Centofanti, P; Ricci, D; Rinaldi, M; Simonato, E | 1 |
| Plosker, GL; Sanford, M | 1 |
| Hess, C | 1 |
| Darius, H | 1 |
| Arnaout, L; Bellamy, L; Rosencher, N | 1 |
| Verma, AK | 1 |
| Weitz, JI | 1 |
| Shakib, S; Tadros, R | 1 |
| Panchenko, EP | 1 |
| Buerke, M; Hamilton, K; Krapiec, F; Linde, T; Maegdefessel, L; Raaz, U; Schlitt, A; Steinseifer, U; van Ryn, J; Werdan, K | 1 |
| Meddahi, S; Samama, MM | 1 |
| Abel, S; Camp, CL; Ereth, MH; McKellar, SH; Schaff, HV; Suri, RM | 1 |
| De Nanteuil, G; Gloanec, P; Marx, I; Mennecier, P; Rupin, A; Vallez, MO; Verbeuren, TJ | 1 |
| Alonso de Leciñana, M; Aparicio, M; Buisan, J; García-Caldentey, J; Guillán, M; Masjuan, J; Matute, MC | 1 |
| Kazmi, RS; Lwaleed, BA | 1 |
| Encinas, J; Ikegami, K; Ohmura, T; Takahashi, I | 1 |
| Spinler, SA; Willey, VJ | 1 |
| Astell, H; Stewart, RA; White, HD; Young, L | 1 |
| Dager, WE; Fanikos, J; Gulseth, MP; Nutescu, EA; Spinler, SA; Wittkowsky, AK | 1 |
| Clemens, A; Härtter, S; Reilly, PA; Stangier, J; Yamamura, N | 1 |
| Barez, A; Martínez, MP; Navarro-Dorado, J; Ramajo, M; Redondo, S; Tejerina, T | 1 |
| Freuler, M; Pezzotti, W | 1 |
| Ageno, W; Crowther, M; Gallus, AS; Hylek, EM; Palareti, G; Wittkowsky, A | 1 |
| Comin, J; Kallmes, DF | 1 |
| Soff, GA | 1 |
| Iyer, V; Reiffel, JA; Singh, HS | 1 |
| Duh, PD; Leuckx, PS; Warnez, PM | 1 |
| Anatoliotakis, N; Deftereos, S; Giannopoulos, G; Kaoukis, A; Mavri, M; Pyrgakis, V; Stefanadis, C | 1 |
| Bianco, RW; Lahti, MT; Medina, EM; Schomburg, JL | 1 |
| Vanerio, G; Vidal, A | 1 |
| Barsness, GW; Caprini, J; Clemens, A; Eriksson, BI; Feuring, M; Hantel, S; Schnee, J; Smith, JJ | 1 |
| Diener, HC; Hohnloser, SH | 1 |
| Dee, S; Jayathissa, S; Thorne, KM | 1 |
| Bunton, R; Chen, VH; Chu, JW | 1 |
| Boodhwani, M; Hynes, M; Labinaz, M; Price, J; Ruel, M | 1 |
| Dovgalevskiĭ, IaP; Furman, NV; Kuvshinova, LE | 1 |
| Valle Bernad, R | 1 |
| Hirayama, H; Inden, Y; Kamiya, H; Murohara, T; Nanasato, M; Nin, T; Sairaku, A; Tatematsu, Y; Yoshida, Y | 1 |
| Ortel, TL | 1 |
| Gross, PL; Weitz, JI | 1 |
| Abrahám, P; Andréka, P; Csillik, A; Földesi, C; Fontos, G; Kardos, A; Kis, Z; Pál, M; Som, Z; Szatmári, A; Temesvári, A | 1 |
| Gustafsson, D | 1 |
| Büller, HR; Di Nisio, M; Middeldorp, S | 1 |
| Eikelboom, JW; Hirsh, J; O'Donnell, M | 1 |
| Hauel, N; Priepke, H; Ries, UJ; Stassen, JM; Wienen, W | 1 |
| Harenberg, J; Wehling, M | 1 |
52 review(s) available for dabigatran and Thrombosis
| Article | Year |
|---|---|
Progress of thrombus formation and research on the structure-activity relationship for antithrombotic drugs.
Topics: Fibrinolytic Agents; Humans; Molecular Structure; Thrombosis | 2022 |
Comparison of non-vitamin K antagonist oral anticoagulants on bleeding and thrombosis.
Topics: Anticoagulants; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; Ischemic Stroke; Pyrazoles; Pyridones; Rivaroxaban; Thrombosis | 2021 |
New Anticoagulants in Neonates, Children, and Adolescents.
Topics: Administration, Oral; Adolescent; Anticoagulants; Child; Dabigatran; Humans; Infant, Newborn; Rivaroxaban; Thrombosis | 2022 |
Comparing the efficacy and safety of direct oral anticoagulants versus Vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis.
Topics: Administration, Oral; Anticoagulants; Antiphospholipid Syndrome; Dabigatran; Fibrinolytic Agents; Hemorrhage; Humans; Rivaroxaban; Thrombosis; Venous Thromboembolism; Vitamin K | 2022 |
[The role of direct oral anticoagulants in the management of cancer-associated thrombosis in 2020].
Topics: Anticoagulants; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; Cytochrome P-450 Enzyme System; Dabigatran; Drug Interactions; Factor Xa Inhibitors; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Neoplasm Proteins; Neoplasms; Pyrazoles; Pyridines; Pyridones; Recurrence; Rivaroxaban; Secondary Prevention; Thiazoles; Thrombosis; Venous Thromboembolism | 2020 |
Use of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombi: A Systematic Review.
Topics: Dabigatran; Factor Xa Inhibitors; Heart Diseases; Heart Ventricles; Humans; Off-Label Use; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thrombosis; Treatment Outcome | 2020 |
Acute limb ischemia in a patient with pre-fibrotic myelofibrosis complicated by heparin-induced thrombocytopenia and thrombosis - case report and systematic review of dabigatran use.
Topics: Anticoagulants; Dabigatran; Heparin; Humans; Ischemia; Male; Middle Aged; Primary Myelofibrosis; Thrombocytopenia; Thrombosis | 2021 |
Noncanonical Effects of Oral Thrombin and Factor Xa Inhibitors in Platelet Activation and Arterial Thrombosis.
Topics: Animals; Blood Coagulation; Dabigatran; Factor Xa Inhibitors; Humans; Platelet Activation; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thrombosis | 2021 |
Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin for Patients With Left Ventricular Thrombus: A Systematic Review and Meta-Analysis.
Topics: Anticoagulants; Antithrombins; Dabigatran; Embolism; Factor Xa Inhibitors; Heart Diseases; Heart Ventricles; Hemorrhage; Humans; Odds Ratio; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thrombosis; Warfarin | 2021 |
Chronic kidney disease and anticoagulation: from vitamin K antagonists and heparins to direct oral anticoagulant agents.
Topics: Administration, Oral; Anticoagulants; Dabigatran; Hemorrhage; Heparin; Humans; Pyrazoles; Pyridones; Renal Insufficiency, Chronic; Rivaroxaban; Thrombosis; Vitamin K | 2017 |
Advances in anticoagulation therapy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Humans; Male; Middle Aged; Pyrazoles; Pyridines; Pyridones; Risk Factors; Rivaroxaban; Stroke; Thiazoles; Thrombosis | 2018 |
A meta-summary of case reports of non-vitamin K antagonist oral anticoagulant use in patients with left ventricular thrombus.
Topics: Administration, Oral; Anticoagulants; Dabigatran; Hemorrhage; Humans; Myocardial Infarction; Pyrazoles; Pyridones; Rivaroxaban; Thrombosis; Ventricular Dysfunction, Left | 2018 |
Dabigatran: life-threatening bleeding.
Topics: Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation Tests; Dabigatran; Drug Interactions; Drug Monitoring; Hemorrhage; Humans; Patient Selection; Risk Assessment; Risk Factors; Thrombosis; Treatment Outcome | 2013 |
[From heparin to apixaban: anticoagulants cut both ways?].
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; Blood Coagulation Tests; Dabigatran; Drug Interactions; Factor Xa Inhibitors; Fondaparinux; Heparin; Humans; International Normalized Ratio; Liver Failure; Metabolic Clearance Rate; Morpholines; Perioperative Care; Polysaccharides; Pyrazoles; Pyridines; Pyridones; Renal Insufficiency; Rivaroxaban; Thiophenes; Thrombocytopenia; Thrombosis; Vitamin K | 2014 |
[The new oral anticoagulants in special populations].
Topics: Administration, Oral; Age Factors; Anticoagulants; Benzimidazoles; Contraindications; Dabigatran; Embolism; Humans; Morpholines; Obesity; Pyrazoles; Pyridines; Pyridones; Renal Insufficiency; Rivaroxaban; Stroke; Thiophenes; Thrombosis | 2012 |
Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats.
Topics: Animals; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Disease Progression; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Liver Cirrhosis; Morpholines; Platelet Aggregation Inhibitors; Rivaroxaban; Thiophenes; Thrombosis; Vitamin K | 2013 |
Novel anticoagulants and laboratory testing.
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation; Blood Coagulation Tests; Dabigatran; Humans; Morpholines; Outcome Assessment, Health Care; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thrombosis | 2013 |
Laboratory monitoring of anticoagulant medications: focus on novel oral anticoagulants.
Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation Tests; Dabigatran; Drug Monitoring; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Thrombosis | 2013 |
Disadvantages of VKA and requirements for novel anticoagulants.
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Dosage Calculations; Drug Interactions; Factor Xa Inhibitors; Humans; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Thrombin; Thrombosis; Vitamin K; Warfarin | 2013 |
New oral anticoagulants and regional anaesthesia.
Topics: Administration, Oral; Anesthesia, Conduction; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Morpholines; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thrombosis | 2013 |
Targeting factor Xa and thrombin: impact on coagulation and beyond.
Topics: Animals; Anti-Inflammatory Agents; Anticoagulants; Atherosclerosis; Benzimidazoles; Blood Coagulation; Clinical Trials, Phase III as Topic; Dabigatran; Drug Evaluation, Preclinical; Factor Xa; Humans; Inflammation; Pyrazoles; Pyridines; Pyridones; Receptors, Proteinase-Activated; Thrombin; Thrombosis | 2014 |
Management of antiplatelet and anticoagulant therapy in patients with atrial fibrillation in the setting of acute coronary syndromes or percutaneous coronary interventions.
Topics: Acute Coronary Syndrome; Adenosine; Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Morpholines; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation Inhibitors; Postoperative Complications; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thrombosis; Ticagrelor | 2014 |
[Gastrointestinal bleeding under treatment with new oral anticoagulants].
Topics: Administration, Oral; Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Gastrointestinal Hemorrhage; Humans; Intracranial Embolism; Morpholines; Postoperative Complications; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Thiophenes; Thrombosis; Vitamin K; Warfarin | 2014 |
Oral anticoagulants: the move beyond warfarin.
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Approval; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thrombosis; Warfarin | 2014 |
Non-vitamin K antagonist oral anticoagulants (NOACs): a view from the laboratory.
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Dose-Response Relationship, Drug; Hemorrhage; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Thrombosis; Treatment Outcome; Vitamin K | 2014 |
Practical recommendations on incorporating new oral anticoagulants into routine practice.
Topics: Administration, Oral; Anticoagulants; Blood Coagulation; Dabigatran; Drug Interactions; Humans; Pyrazoles; Pyridones; Rivaroxaban; Thrombosis | 2014 |
Reversal of anticoagulants: an overview of current developments.
Topics: Administration, Oral; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticoagulants; Antithrombins; Benzamides; Clinical Trials as Topic; Dabigatran; Factor Xa; Factor Xa Inhibitors; Fondaparinux; Hemorrhage; Hemostatics; Heparin; Humans; Infusions, Parenteral; Intracranial Hemorrhages; Polysaccharides; Protamines; Pyrazoles; Pyridines; Pyridones; Recombinant Proteins; Rivaroxaban; Thiazoles; Thrombosis; Vitamin K | 2015 |
Dose tailoring of dabigatran etexilate: obvious or excessive?
Topics: Antithrombins; Dabigatran; Dose-Response Relationship, Drug; Genetic Variation; Hemorrhage; Humans; Thrombosis | 2015 |
New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint.
Topics: Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Clopidogrel; Dabigatran; Drug Combinations; Factor Xa Inhibitors; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Stents; Thrombosis; Ticlopidine; Warfarin | 2015 |
[Novel oral anticoagulants--issues in clinical practice].
Topics: Administration, Oral; Anticoagulants; Dabigatran; Humans; Perioperative Care; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thrombosis | 2015 |
[Companion Diagnostics for Thrombotic Disease].
Topics: Administration, Oral; Anticoagulants; Cytochrome P-450 CYP2C9; Dabigatran; Humans; Pharmacogenetics; Polymorphism, Single Nucleotide; Precision Medicine; Thrombosis; Vitamin K Epoxide Reductases; Warfarin | 2015 |
[Coagulation disorders in the intensive care unit - what is new?].
Topics: Anticoagulants; Dabigatran; Hemophilia A; Hemorrhage; Heparin; Humans; Intensive Care Units; Rivaroxaban; Thrombocytopenia; Thrombosis; Warfarin | 2016 |
Should new oral anticoagulants replace low-molecular-weight heparin for thromboprophylaxis in orthopaedic surgery?
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; Dabigatran; Drug Administration Schedule; Factor Xa Inhibitors; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Morpholines; Orthopedic Procedures; Prothrombin; Pyridines; Risk Assessment; Rivaroxaban; Thiophenes; Thrombosis; Vitamin K | 2009 |
Potential of new anticoagulants in patients with cancer.
Topics: Anticoagulants; Benzimidazoles; Biotin; Clinical Trials as Topic; Dabigatran; Humans; Morpholines; Neoplasms; Oligosaccharides; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Thrombosis | 2010 |
Clot prevention--common questions about medications.
Topics: Anticoagulants; Aspirin; Benzimidazoles; Dabigatran; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; International Normalized Ratio; Morpholines; Pharmacogenetics; Pyridines; Risk Factors; Rivaroxaban; Thiophenes; Thrombosis; Venous Thromboembolism | 2010 |
New anticoagulants: how to deal with treatment failure and bleeding complications.
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Morpholines; Rivaroxaban; Thiophenes; Thromboembolism; Thrombosis; Treatment Failure | 2011 |
[Pharmacological and clinical profiles of the direct thrombin inhibitor dabigatran etexilate methane sulfate (Prazaxa(®)) ].
Topics: Animals; Antithrombins; Benzimidazoles; Dabigatran; Haplorhini; Humans; Pyridines; Rats; Stroke; Thrombosis; Warfarin | 2011 |
Dabigatran etexilate in clinical practice: confronting challenges to improve safety and effectiveness.
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; Dabigatran; Drug Approval; Drug Design; Female; Humans; Practice Guidelines as Topic; Pregnancy; Pyridines; Thrombin; Thrombosis; United States; United States Food and Drug Administration | 2011 |
Pharmacological basis and clinical evidence of dabigatran therapy.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Kidney Failure, Chronic; Thrombosis | 2011 |
Using anticoagulants to steer clear of clots.
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Heparin; Humans; Thrombosis; Warfarin | 2012 |
Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Topics: Administration, Oral; Anticoagulants; Antithrombins; Benzimidazoles; Dabigatran; Dose-Response Relationship, Drug; Evidence-Based Medicine; Factor Xa; Factor Xa Inhibitors; Humans; Morpholines; Practice Guidelines as Topic; Pyridines; Rivaroxaban; Societies, Medical; Thiophenes; Thrombosis; United States; Vitamin K | 2012 |
A new generation of oral direct anticoagulants.
Topics: Acute Coronary Syndrome; Administration, Oral; Animals; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Hemorrhage; Humans; Morpholines; Orthopedic Procedures; Pyrazoles; Pyridones; Risk Assessment; Risk Factors; Rivaroxaban; Thiophenes; Thrombosis; Treatment Outcome | 2012 |
Dabigatran: comparison to warfarin, pathway to approval, and practical guidelines for use.
Topics: Antithrombins; Atrial Fibrillation; Benzimidazoles; Dabigatran; Humans; Pyridines; Stroke; Thrombosis; Warfarin | 2012 |
[Pharmacological sheet. Dabigatran, oral administration (Pradaxa)].
Topics: Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Interactions; Fibrinolytic Agents; Humans; Thrombosis; Venous Thromboembolism | 2012 |
Novel direct factor IIa and Xa inhibitors: mechanisms of action and preclinical studies.
Topics: Animals; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Evaluation, Preclinical; Factor Xa; Factor Xa Inhibitors; Humans; Prothrombin; Thrombosis | 2012 |
Dabigatran and left atrial appendage thrombus.
Topics: Antithrombins; Atrial Appendage; Benzimidazoles; beta-Alanine; Dabigatran; Female; Heart Diseases; Humans; Middle Aged; Thrombosis; Warfarin | 2012 |
[Anticoagulant therapy in connection with cardioversion in patients with atrial fibrillation].
Topics: Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Biological Availability; Blood Coagulation; Dabigatran; Drug Monitoring; Echocardiography, Transesophageal; Electric Countershock; Female; Heart Atria; Heart Rate; Hemorrhage; Humans; Male; Middle Aged; Pharmacovigilance; Risk Adjustment; Thrombosis; Treatment Outcome | 2012 |
Perioperative management of patients on chronic antithrombotic therapy.
Topics: Administration, Oral; Aged; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Fibrinolytic Agents; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Middle Aged; Morpholines; Perioperative Care; Risk; Rivaroxaban; Thiophenes; Thromboembolism; Thrombosis; Vitamin K | 2012 |
New oral anticoagulants: which one should my patient use?
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Chemistry, Pharmaceutical; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Hematology; Humans; Morpholines; Rivaroxaban; Thiophenes; Thrombin; Thrombosis; Warfarin | 2012 |
Oral direct thrombin inhibitors in clinical development.
Topics: Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Dabigatran; Glycine; Hemostasis; Humans; Prodrugs; Pyridines; Stroke; Thrombin; Thrombosis; Venous Thrombosis; Vitamin K | 2003 |
Beyond unfractionated heparin and warfarin: current and future advances.
Topics: Angina, Unstable; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Brain Ischemia; Clinical Trials as Topic; Coumarins; Dabigatran; Factor Xa Inhibitors; Fibrinolytic Agents; Fondaparinux; Forecasting; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Morpholines; Myocardial Infarction; Peptide Fragments; Polysaccharides; Prothrombin; Pyrazoles; Pyridines; Pyridones; Recombinant Proteins; Rivaroxaban; Thiophenes; Thrombin; Thrombophilia; Thrombosis; Warfarin | 2007 |
Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIa.
Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Atrial Fibrillation; Azetidines; Benzimidazoles; Benzylamines; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Glycine; Humans; Infusions, Parenteral; Morpholines; Oligosaccharides; Piperazines; Prothrombin; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Thrombin; Thrombosis; Venous Thromboembolism | 2008 |
16 trial(s) available for dabigatran and Thrombosis
| Article | Year |
|---|---|
Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Defibrillators, Implantable; Drug Administration Schedule; Drug Substitution; Female; Hematoma; Hemorrhage; Heparin; Humans; Male; Middle Aged; Pacemaker, Artificial; Prosthesis Implantation; Thrombosis; Time Factors; Treatment Outcome; Warfarin | 2017 |
Idarucizumab for Dabigatran Reversal - Full Cohort Analysis.
Topics: Adult; Aged; Aged, 80 and over; Antibodies; Antibodies, Monoclonal, Humanized; Anticoagulants; Blood Coagulation; Dabigatran; Drug Hypersensitivity; Female; Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Thrombin Time; Thrombosis; Time Factors | 2017 |
Targeting Coagulase Activity in Staphylococcus aureus Bacteraemia: A Randomized Controlled Single-Centre Trial of Staphylothrombin Inhibition.
Topics: Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Arginine; Bacteremia; Belgium; Blood Coagulation; Coagulase; Dabigatran; Enoxaparin; Feasibility Studies; Female; Hemorrhage; Humans; Injections, Subcutaneous; Male; Middle Aged; Partial Thromboplastin Time; Pilot Projects; Pipecolic Acids; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Sulfonamides; Thrombin; Thrombosis; Time Factors; Treatment Outcome | 2018 |
Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial.
Topics: Aged; Aged, 80 and over; Antithrombins; Dabigatran; Female; Hemorrhage; Humans; Male; Myocardial Infarction; Omeprazole; Perioperative Period; Peripheral Arterial Disease; Placebo Effect; Proton Pump Inhibitors; Stroke; Thrombosis; Treatment Outcome; Troponin; Venous Thromboembolism | 2018 |
Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study.
Topics: Adolescent; Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Dabigatran; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Male; Middle Aged; Norway; Pharmacoepidemiology; Risk Factors; Rivaroxaban; Thrombosis; Warfarin | 2018 |
Dual Anti-Thrombotic Therapy With Dabigatran After Percutaneous Coronary Intervention in Atrial Fibrillation - Japanese and East-Asian Subgroup Analysis of the RE-DUAL PCI Trial.
Topics: Aged; Aged, 80 and over; Anticoagulants; Asian People; Atrial Fibrillation; Dabigatran; Female; Fibrinolytic Agents; Humans; Japan; Male; Middle Aged; Percutaneous Coronary Intervention; Thrombosis; Treatment Outcome; Warfarin | 2019 |
[Re-allign (randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran ftexilate in patients after heart valve replacement)].
Topics: Administration, Oral; Adolescent; Adult; Aged; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Female; Heart Valve Prosthesis Implantation; Humans; Male; Metabolic Clearance Rate; Middle Aged; Thrombosis; Tissue Distribution; Treatment Outcome; Young Adult | 2014 |
Antithrombotic triple therapy and coagulation activation at the site of thrombus formation: a randomized trial in healthy subjects.
Topics: Adenosine; Administration, Oral; Adult; Anticoagulants; Antithrombin III; Aspirin; Austria; Benzimidazoles; beta-Alanine; beta-Thromboglobulin; Biomarkers; Blood Coagulation; Blood Platelets; Dabigatran; Drug Therapy, Combination; Fibrinolytic Agents; Healthy Volunteers; Humans; International Normalized Ratio; Male; Morpholines; Peptide Fragments; Peptide Hydrolases; Phenprocoumon; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Prothrombin; Rivaroxaban; Thiophenes; Thrombin; Thrombosis; Ticagrelor; Young Adult | 2014 |
Uninterrupted dabigatran versus warfarin in the treatment of intracardiac thrombus in patients with non-valvular atrial fibrillation.
Topics: Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Thrombosis; Treatment Outcome; Ultrasonography; Warfarin | 2015 |
Idarucizumab for Dabigatran Reversal.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Female; Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Thrombosis | 2015 |
Rationale and design of the RE-LATED AF--AFNET 7 trial: REsolution of Left atrial-Appendage Thrombus--Effects of Dabigatran in patients with Atrial Fibrillation.
Topics: Anticoagulants; Antithrombins; Atrial Appendage; Atrial Fibrillation; Dabigatran; Echocardiography, Transesophageal; Humans; Phenprocoumon; Prospective Studies; Research Design; Thrombosis | 2016 |
Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results from a prospective, randomised, double-blind, placebo-controlled study.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Clopidogrel; Coronary Artery Disease; Cytochrome P-450 Enzyme System; Dabigatran; Double-Blind Method; Electrodes; Female; Humans; Light; Male; Middle Aged; Nephelometry and Turbidimetry; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Thrombelastography; Thrombosis; Ticlopidine; Vitamin K | 2016 |
Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study.
Topics: Adolescent; Adult; Antithrombins; Atrial Fibrillation; Bioprosthesis; Cardiac Valve Annuloplasty; Dabigatran; Female; Heart Diseases; Humans; Male; Middle Aged; Pilot Projects; Thrombosis; Treatment Outcome; Warfarin; Young Adult | 2016 |
Incidence of left atrial abnormalities under treatment with dabigatran, rivaroxaban, and vitamin K antagonists.
Topics: Aged; Atrial Fibrillation; Atrial Flutter; Atrial Function, Left; Dabigatran; Electrocardiography; Female; Heart Atria; Humans; Male; Middle Aged; Rivaroxaban; Thrombosis; Vitamin K | 2016 |
Evaluation of the acute coronary syndrome safety profile of dabigatran etexilate in patients undergoing major orthopedic surgery: findings from four Phase 3 trials.
Topics: Acute Coronary Syndrome; Adult; Aged; Anticoagulants; Benzimidazoles; Dabigatran; Drug-Related Side Effects and Adverse Reactions; Humans; Incidence; Internationality; Male; Middle Aged; Orthopedics; Postoperative Complications; Pyridines; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Thrombosis; Treatment Outcome | 2012 |
A randomized controlled trial of dabigatran versus warfarin for periablation anticoagulation in patients undergoing ablation of atrial fibrillation.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Male; Middle Aged; Perioperative Care; Premedication; Thrombosis; Treatment Outcome; Warfarin | 2013 |
119 other study(ies) available for dabigatran and Thrombosis
| Article | Year |
|---|---|
Molecular design, synthesis and anticoagulant activity evaluation of fluorinated dabigatran analogues.
Topics: Animals; Anticoagulants; Antithrombins; Dabigatran; Drug Design; Halogenation; Humans; Molecular Docking Simulation; Rats, Sprague-Dawley; Structure-Activity Relationship; Thrombin; Thrombosis | 2016 |
Design, synthesis, anticoagulant activity evaluation and molecular docking studies of a class of N-ethyl dabigatran derivatives.
Topics: Anticoagulants; Antithrombins; Dabigatran; Drug Design; Humans; Molecular Docking Simulation; Structure-Activity Relationship; Thrombosis | 2016 |
Adverse events in patients taking apixaban or rivaroxaban who have undergone bariatric surgery: a retrospective case series.
Topics: Administration, Oral; Adult; Anticoagulants; Atrial Fibrillation; Bariatric Surgery; Dabigatran; Hemorrhage; Humans; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Thromboembolism; Thrombosis | 2022 |
Assessment of exposure to direct oral anticoagulants in elderly hospitalised patients.
Topics: Age Factors; Aged; Aged, 80 and over; Dabigatran; Drug Monitoring; Factor Xa Inhibitors; Female; Hospitalization; Humans; Male; Pyrazoles; Pyridones; Rivaroxaban; Thrombosis | 2021 |
Safety and efficacy of low-dose non-vitamin K antagonist oral anticoagulants versus warfarin after left atrial appendage closure with the Watchman device.
Topics: Administration, Oral; Anticoagulants; Atrial Appendage; Atrial Fibrillation; Dabigatran; Hemorrhage; Humans; Rivaroxaban; Stroke; Thrombosis; Treatment Outcome; Warfarin | 2022 |
Retrospective Analysis of the Effectiveness of a Reduced Dose of Idarucizumab in Dabigatran Reversal.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antithrombins; Blood Coagulation; Dabigatran; Hemorrhage; Humans; Retrospective Studies; Thrombosis | 2022 |
Thrombotic events and rebleeding after hemorrhage in patients taking direct oral anticoagulants for non-valvular atrial fibrillation.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Male; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Thiazoles; Thrombosis | 2021 |
A Multicenter Retrospective Evaluation of Direct Oral Anticoagulants for the Treatment of Heparin-Induced Thrombocytopenia.
Topics: Administration, Oral; Adult; Anticoagulants; Dabigatran; Hemorrhage; Humans; Retrospective Studies; Rivaroxaban; Thrombocytopenia; Thrombosis | 2022 |
Rivaroxaban Reduces the Dabigatran Dose Required for Anticoagulation During Simulated Cardiopulmonary Bypass.
Topics: Anticoagulants; Cardiopulmonary Bypass; Dabigatran; Fibrin; Heparin; Humans; Rivaroxaban; Thrombosis | 2022 |
Complete primary aortic ascending thrombosis resolution after dabigatran therapy.
Topics: Antithrombins; Aortic Diseases; Dabigatran; Humans; Thrombosis | 2022 |
Differences in the predictors of left atrial appendage thrombus between men and women treated with dabigatran or rivaroxaban.
Topics: Anticoagulants; Atrial Appendage; Atrial Fibrillation; Dabigatran; Female; Heart Diseases; Humans; Male; Retrospective Studies; Rivaroxaban; Thrombosis | 2022 |
An Overview of Thrombin Inhibitors in the Perspective of Structureactivity Relationships.
Topics: Anticoagulants; Dabigatran; Hemorrhage; Humans; Thrombin; Thrombosis | 2023 |
[Mitral Mechanical Valve Thrombosis after Switching to Dabigatran].
Topics: Aged; Anticoagulants; Dabigatran; Heart Valve Prosthesis; Humans; Male; Mitral Valve; Thrombosis; Warfarin | 2022 |
Intravenous Dabigatran Provides Adequate Anticoagulation for Cardiopulmonary Bypass Using a Rabbit Model.
Topics: Animals; Anticoagulants; Cardiopulmonary Bypass; Dabigatran; Heparin; Rabbits; Thrombosis | 2023 |
Outcome of Anticoagulation Therapy of Left Atrial Thrombus or Sludge in Patients With Nonvalvular Atrial Fibrillation or Flutter.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Drug Therapy, Combination; Echocardiography, Transesophageal; Female; Heart Atria; Humans; Male; Middle Aged; Rivaroxaban; Thrombosis; Treatment Outcome; Warfarin | 2019 |
Long-Term Dabigatran Treatment Delays Alzheimer's Disease Pathogenesis in the TgCRND8 Mouse Model.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Anticoagulants; Blood-Brain Barrier; Cerebral Cortex; Dabigatran; Disease Models, Animal; Female; Fibrin; Hemostasis; Hippocampus; Maze Learning; Memory; Mice; Mice, Transgenic; Neurodegenerative Diseases; Perfusion; Thrombosis | 2019 |
Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve-Induced Thrombin Generation.
Topics: Antithrombins; Dabigatran; Factor Xa Inhibitors; Heart Diseases; Heart Valve Prosthesis; Humans; Rivaroxaban; Thrombin; Thrombosis | 2020 |
Outcome of non-vitamin K oral anticoagulants in the treatment of left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.
Topics: Administration, Oral; Aged; Antithrombins; Atrial Appendage; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Retrospective Studies; Rivaroxaban; Stroke; Thrombosis; Time Factors; Treatment Outcome | 2020 |
Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran.
Topics: Adolescent; Adult; Anticoagulants; Antithrombins; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B; Carboxylic Ester Hydrolases; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Dabigatran; Female; Genotype; Humans; Male; Middle Aged; Organic Cation Transporter 1; Pantoprazole; Pharmacogenetics; Polymorphism, Genetic; Proton Pump Inhibitors; Sex Factors; Spain; Thrombosis; Young Adult | 2020 |
High-Dose Dabigatran Is an Effective Anticoagulant for Simulated Cardiopulmonary Bypass Using Human Blood.
Topics: Adult; Antithrombins; Blood Coagulation; Cardiopulmonary Bypass; Dabigatran; Dose-Response Relationship, Drug; Humans; Middle Aged; Proof of Concept Study; Thrombelastography; Thrombosis; Time Factors; Young Adult | 2021 |
Left atrial appendage thrombus formation in a patient with atrial fibrillation on dabigatran therapy associated with CES1 and ABCB1 genetic polymorphisms: A case report.
Topics: Antithrombins; ATP Binding Cassette Transporter, Subfamily B; Atrial Appendage; Atrial Fibrillation; Carboxylic Ester Hydrolases; Dabigatran; Female; Humans; Middle Aged; Thrombosis | 2020 |
Therapeutic Drug Monitoring of Direct Oral Anticoagulants May Increase Their Benefit-Risk Ratio.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antithrombins; Blood Coagulation; Chromatography, High Pressure Liquid; Dabigatran; Drug Monitoring; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Patient Safety; Predictive Value of Tests; Prospective Studies; Risk Assessment; Risk Factors; Rivaroxaban; Tandem Mass Spectrometry; Thrombosis; Treatment Outcome | 2020 |
Observations on clot properties in atrial fibrillation: Relation to renal function and choice of anticoagulant.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Humans; Pyridones; Rivaroxaban; Stroke; Thrombosis; Warfarin | 2021 |
Appropriate Use of Idarucizumab for Dabigatran Reversal According to the International Society on Thrombosis and Hemostasis and French Working Group on Perioperative Hemostasis: A French Retrospective Study.
Topics: Antibodies, Monoclonal, Humanized; Antithrombins; Dabigatran; Hemostasis; Humans; Retrospective Studies; Thrombosis | 2021 |
How lower doses of direct oral anticoagulants are interpreted in clinical practice: a national survey of the Italian Atherosclerosis, Thrombosis and Vascular Biology (ATVB) Study Group.
Topics: Administration, Oral; Anticoagulants; Atherosclerosis; Atrial Fibrillation; Dabigatran; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Humans; Italy; Pyrazoles; Pyridines; Pyridones; Renal Insufficiency; Rivaroxaban; Surveys and Questionnaires; Thiazoles; Thrombosis; Treatment Outcome | 2021 |
Ex Vivo Assessment of Different Oral Anticoagulant Regimens on Pump Thrombosis in a HeartWare Ventricular Assist Device.
Topics: Anticoagulants; Blood Coagulation; Dabigatran; Heart Failure; Heart-Assist Devices; Hemolysis; Humans; Platelet Aggregation Inhibitors; Thrombosis; Warfarin | 2021 |
A comparison of apixaban and dabigatran etexilate for thromboprophylaxis following hip and knee replacement surgery.
Topics: Adult; Aged; Aged, 80 and over; Antithrombins; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Dabigatran; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Osteoarthritis, Hip; Osteoarthritis, Knee; Postoperative Complications; Pyrazoles; Pyridones; Thrombosis; Treatment Outcome | 2017 |
In-vitro assessment of the effect of dabigatran on thrombosis of adult and neonatal plasma: comparisons using thromboelastography and microscopic visualization of fibrin clot structure.
Topics: Adult; Antithrombins; Dabigatran; Female; Fibrin Clot Lysis Time; Humans; Infant, Newborn; Male; Microscopy, Electron, Scanning; Thrombelastography; Thrombosis; Young Adult | 2017 |
Dabigatran Therapy Resulting in the Resolution of Rivaroxaban-resistant Left Atrial Appendage Thrombi in Patients with Atrial Fibrillation.
Topics: Aged; Antithrombins; Atrial Appendage; Atrial Fibrillation; Dabigatran; Echocardiography, Transesophageal; Heart Atria; Humans; Male; Rivaroxaban; Thrombosis | 2017 |
Direct Oral Anticoagulants Form Thrombus Different From Warfarin in a Microchip Flow Chamber System.
Topics: Administration, Oral; Aged; Anticoagulants; Area Under Curve; Atrial Fibrillation; Dabigatran; Female; Humans; Lab-On-A-Chip Devices; Male; Middle Aged; Pyrazoles; Pyridones; Rivaroxaban; Thrombosis; Warfarin | 2017 |
Comparison of Prescribing Practices with Direct Acting Oral Anticoagulant Protocols.
Topics: Administration, Oral; Adult; Age Factors; Aged; Algorithms; Anticoagulants; Cohort Studies; Dabigatran; Female; Guideline Adherence; Hemorrhage; Humans; Male; Middle Aged; Off-Label Use; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Thrombosis | 2017 |
Thrombosis on a left atrial appendage occluder device: the double-edged sword of stroke prevention strategies in atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Dabigatran; Echocardiography, Three-Dimensional; Humans; Male; Septal Occluder Device; Stroke; Thrombosis; Treatment Outcome | 2017 |
Newly developed left ventricular apical thrombus under dabigatran treatment.
Topics: Antithrombins; Dabigatran; Humans; Male; Middle Aged; Thrombosis | 2018 |
Anticoagulation prescribing patterns in patients with cancer.
Topics: Adult; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Enoxaparin; Hemorrhage; Humans; Middle Aged; Neoplasms; Practice Patterns, Physicians'; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Thrombosis; Treatment Outcome; Venous Thromboembolism; Warfarin | 2018 |
What is the significance, if any, of the increased incidence of stent thrombosis with dual therapy of dabigatran 110mg twice daily and clopidogrel in the RE-DUAL PCI trial?
Topics: Clopidogrel; Dabigatran; Drug Therapy, Combination; Humans; Incidence; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Stents; Thrombosis; Ticlopidine; Treatment Outcome | 2018 |
Methodological challenges when evaluating potential off-label prescribing of drugs using electronic health care databases: A case study of dabigatran etexilate in Europe.
Topics: Aged; Aged, 80 and over; Antithrombins; Cross-Sectional Studies; Dabigatran; Databases, Factual; Electronic Health Records; Europe; Female; Humans; Male; Middle Aged; Off-Label Use; Primary Health Care; Thrombosis | 2018 |
Dual anticoagulation with fondaparinux and dabigatran for treatment of cancer-associated hypercoagulability.
Topics: Adult; Anticoagulants; Antithrombins; Dabigatran; Drug Therapy, Combination; Factor Xa Inhibitors; Fondaparinux; Humans; Lung Neoplasms; Male; Recurrence; Thrombophilia; Thrombosis; Venous Thromboembolism | 2018 |
Left atrial thrombus and dense spontaneous echocardiographic contrast in patients on continuous direct oral anticoagulant therapy undergoing catheter ablation of atrial fibrillation: Comparison of dabigatran, rivaroxaban, and apixaban.
Topics: Administration, Oral; Aged; Antithrombins; Atrial Fibrillation; Catheter Ablation; Contrast Media; Dabigatran; Dose-Response Relationship, Drug; Echocardiography, Transesophageal; Factor Xa Inhibitors; Female; Heart Atria; Heart Diseases; Humans; Male; Middle Aged; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Thrombosis | 2018 |
Complete resolution of left atrial appendage thrombosis with oral dabigatran etexilate in a patient with Myotonic Dystrophy type 1 and atrial fibrillation.
Topics: Administration, Oral; Antithrombins; Atrial Fibrillation; Dabigatran; Female; Heart Atria; Humans; Middle Aged; Myotonic Dystrophy; Thrombosis | 2017 |
Left ventricular mural thrombus despite treatment with dabigatran and clopidogrel.
Topics: Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Clopidogrel; Dabigatran; Diagnosis, Differential; Drug Therapy, Combination; Dyspnea; Echocardiography; Fatal Outcome; Heart Diseases; Heart Failure; Humans; Male; Thrombosis; Ticlopidine; Warfarin | 2018 |
Anticoagulation efficacy of dabigatran etexilate for left atrial appendage thrombus in patients with atrial fibrillation by transthoracic and transesophageal echocardiography.
Topics: Aged; Antithrombins; Atrial Appendage; Atrial Fibrillation; Blood Flow Velocity; Dabigatran; Echocardiography; Echocardiography, Transesophageal; Female; Heart Atria; Humans; Male; Middle Aged; Stroke Volume; Thrombosis; Treatment Outcome; Ventricular Function, Left | 2018 |
Assessment of patients post reversal with idarucizumab.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antithrombins; Blood Coagulation; Dabigatran; Drug Interactions; Hemorrhage; Hemostasis; Humans; Thromboembolism; Thrombosis; Time Factors; Treatment Outcome | 2018 |
Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antidotes; Antithrombins; Atrial Fibrillation; Blood Coagulation; Dabigatran; Female; Hemorrhage; Hemostasis; Humans; Intracranial Hemorrhages; Male; Middle Aged; Thrombosis; Treatment Outcome | 2019 |
Dabigatran as an alternative for atrial thrombosis resistant to rivaroxaban: A case report.
Topics: Antithrombins; Atrial Fibrillation; Dabigatran; Drug Resistance; Heart Atria; Heart Diseases; Humans; Male; Middle Aged; Rivaroxaban; Thrombosis | 2018 |
Bioprosthetic mitral valve thrombosis resolved with dabigatran.
Topics: Aged, 80 and over; Antithrombins; Bioprosthesis; Dabigatran; Echocardiography, Transesophageal; Heart Valve Prosthesis; Humans; Male; Mitral Valve; Prosthesis Failure; Thrombosis | 2020 |
Safety of radial coronary angiography with uninterrupted direct-acting oral anticoagulant treatment.
Topics: Aged; Anticoagulants; Cardiac Catheterization; Coronary Angiography; Dabigatran; Female; Hematoma; Humans; Male; Middle Aged; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Thrombosis | 2019 |
Effects of Bemiparin Sodium Versus Dabigatran Etexilate After Anastomosis in Rat Carotid Arteries on the Development of Neointima and Thrombolytic Efficacy.
Topics: Animals; Anticoagulants; Antithrombins; Carotid Arteries; Cerebral Revascularization; Dabigatran; Heparin, Low-Molecular-Weight; Neointima; Rats; Rats, Sprague-Dawley; Thrombosis | 2019 |
Are Intervertebral Disc Tissue Cells Damaged When Attempting to Prevent Thrombus Formation Using Dabigatran, A New Oral Anticoagulant?
Topics: Administration, Oral; Adolescent; Adult; Anticoagulants; Cell Survival; Dabigatran; Extracellular Matrix Proteins; Female; Gene Expression; Humans; Intervertebral Disc; Intervertebral Disc Degeneration; Male; Middle Aged; Primary Cell Culture; Thrombosis; Young Adult | 2019 |
Efficacy of Direct Acting Oral Anticoagulants in Treatment of Left Ventricular Thrombus.
Topics: Adult; Aged; Blood Transfusion; Dabigatran; Echocardiography; Epistaxis; Factor Xa Inhibitors; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Heart Ventricles; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Thrombosis; Ventricular Dysfunction, Left | 2019 |
Genetic and pharmacological modifications of thrombin formation in apolipoprotein e-deficient mice determine atherosclerosis severity and atherothrombosis onset in a neutrophil-dependent manner.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Benzimidazoles; Blood Coagulation; Dabigatran; Disease Models, Animal; Disease Progression; Female; Hematopoiesis; Inflammation; Mice; Mice, Knockout; Neutrophils; Phenotype; Plaque, Atherosclerotic; Pyridines; Reactive Oxygen Species; Thrombin; Thrombosis | 2013 |
Antithrombotic activity of HY023016, a novel Dabigatran prodrug evaluated in animal thrombosis models.
Topics: Animals; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Disease Models, Animal; Mice; Prodrugs; Rabbits; Rats; RNA, Messenger; Thrombin; Thromboplastin; Thrombosis | 2013 |
A new oral anticoagulant in the setting of dermatologic surgery.
Topics: Administration, Oral; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Dermatologic Surgical Procedures; Humans; Postoperative Complications; Thrombosis | 2013 |
Thrombolytic action of dabigatran in patients with acute pre-existing atrial thrombus.
Topics: Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Echocardiography, Transesophageal; Female; Heart Atria; Heart Diseases; Humans; Male; Thrombosis; Treatment Outcome | 2013 |
Massive left atrial thrombus in a patient with rheumatic mitral stenosis and atrial fibrillation while anticoagulated with dabigatran.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Substitution; Echocardiography; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Mitral Valve Stenosis; Rheumatic Heart Disease; Thrombosis; Treatment Outcome; Warfarin | 2013 |
Dabigatran for left atrial thrombus.
Topics: Aged; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Female; Heart Atria; Heart Diseases; Humans; Thrombosis | 2013 |
Thrombosis on a mechanical mitral valve anticoagulated with dabigatran.
Topics: Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Heart Valve Prosthesis; Humans; Male; Mitral Valve; Thrombosis | 2014 |
Dabigatran and mechanical valves: less effective and more risky than warfarin.
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Postoperative Complications; Thrombosis; Warfarin | 2013 |
Dabigatran for thromboprophylaxis after robotic assisted laparoscopic prostatectomy: retrospective analysis of safety profile and effect on blood coagulation.
Topics: Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Humans; Laparoscopy; Male; Middle Aged; Postoperative Complications; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Robotics; Thrombosis | 2014 |
Dabigatran - neurosurgical anathema?
Topics: Aged; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Male; Risk Assessment; Stroke; Thrombosis; Warfarin | 2013 |
Resolution of a left ventricular thrombus by the thrombolytic action of dabigatran.
Topics: Aged; Benzimidazoles; beta-Alanine; Dabigatran; Fibrinolytic Agents; Heart Diseases; Heart Ventricles; Humans; Incidental Findings; Male; Predictive Value of Tests; Thrombolytic Therapy; Thrombosis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2014 |
[Severe thrombosis of bioprosthesis mitral valve after dabigatran].
Topics: Adult; Antithrombins; Benzimidazoles; beta-Alanine; Bioprosthesis; Dabigatran; Female; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Mitral Valve Insufficiency; Prosthesis-Related Infections; Thrombosis | 2013 |
Anticoagulation without monitoring.
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Monitoring; Hemorrhage; Heparin; Humans; Morpholines; Pharmacovigilance; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thrombosis; Warfarin | 2013 |
Management of dabigatran-induced bleeding: expert statement.
Topics: Administration, Oral; Antithrombins; Austria; Benzimidazoles; beta-Alanine; Blood Coagulation Tests; Dabigatran; Dose-Response Relationship, Drug; Humans; Monitoring, Intraoperative; Postoperative Hemorrhage; Practice Guidelines as Topic; Thrombosis | 2013 |
The antithrombotic effect of dabigatran.
Topics: Aged; Antithrombins; Atrial Appendage; Benzimidazoles; beta-Alanine; Dabigatran; Diagnosis, Differential; Echocardiography; Follow-Up Studies; Heart Diseases; Humans; Magnetic Resonance Imaging, Cine; Male; Multidetector Computed Tomography; Thrombosis | 2014 |
Comparative evaluation of direct thrombin and factor Xa inhibitors with antiplatelet agents under flow and static conditions: an in vitro flow chamber model.
Topics: Adenosine Triphosphate; Adult; Anticoagulants; Antithrombins; Aspirin; Benzimidazoles; beta-Alanine; Blood Platelets; Dabigatran; Dose-Response Relationship, Drug; Factor Xa; Factor Xa Inhibitors; Female; Fibrin; Humans; Lab-On-A-Chip Devices; Male; Microscopy, Confocal; Morpholines; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Rivaroxaban; Thiophenes; Thrombin; Thromboplastin; Thrombosis | 2014 |
Only high levels of dabigatran attenuate catheter thrombosis in vitro and in rabbits.
Topics: Animals; Antithrombins; Benzimidazoles; beta-Alanine; Catheter Obstruction; Catheters; Dabigatran; Drug Dosage Calculations; Heart Valve Prosthesis Implantation; Heparin; Humans; In Vitro Techniques; Male; Models, Animal; Postoperative Complications; Rabbits; Thrombin; Thromboembolism; Thrombosis | 2014 |
Myocardial infarction complicated by left ventricular thrombus and fatal thromboembolism following abrupt cessation of dabigatran.
Topics: Aged, 80 and over; Angiography; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Fatal Outcome; Heart Diseases; Heart Ventricles; Humans; Male; Mesenteric Artery, Superior; Myocardial Infarction; Thromboembolism; Thrombosis; Tomography, X-Ray Computed | 2014 |
Anticoagulant treatment in German family practices - screening results from a cluster randomized controlled trial.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Coumarins; Dabigatran; Family Practice; Female; Germany; Guideline Adherence; Heart Diseases; Heart Valve Prosthesis; Humans; International Normalized Ratio; Male; Mass Screening; Middle Aged; Morpholines; Practice Guidelines as Topic; Process Assessment, Health Care; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Thrombosis; Venous Thromboembolism | 2014 |
[Thrombosis of a mechanical prosthetic mitral valve during dabigatran treatment].
Topics: Aged; Anticoagulants; Antithrombins; Dabigatran; Echocardiography, Transesophageal; Heart Valve Prosthesis; Humans; Male; Mitral Valve; Shock, Cardiogenic; Thrombosis; Warfarin | 2014 |
Prevalence of intracardiac thrombi under phenprocoumon, direct oral anticoagulants (dabigatran and rivaroxaban), and bridging therapy in patients with atrial fibrillation and flutter.
Topics: Aged; Anticoagulants; Arrhythmias, Cardiac; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Electric Countershock; Female; Humans; Male; Middle Aged; Morpholines; Phenprocoumon; Prevalence; Rivaroxaban; Thiophenes; Thrombosis; Vitamin K | 2015 |
Case images: warfarin-induced skin necrosis: a 'novel' solution to an old problem.
Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Diagnosis, Differential; Humans; Ischemic Attack, Transient; Male; Middle Aged; Necrosis; Skin; Skin Diseases; Thrombosis; Warfarin | 2014 |
A protruding lesion on the previous pulmonary vein isolation line in a case with paroxysmal atrial fibrillation.
Topics: Aged; Antithrombins; Atrial Fibrillation; Catheter Ablation; Dabigatran; Echocardiography, Transesophageal; Female; Humans; Postoperative Complications; Pulmonary Veins; Thrombosis; Treatment Failure | 2015 |
[Antidote to dabigatran].
Topics: Antibodies, Monoclonal, Humanized; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Risk Factors; Thrombosis | 2015 |
Effects of Dabigatran on the Resolution of Left Ventricular Thrombus after Acute Myocardial Infarction.
Topics: Aged; Antithrombins; Chest Pain; Dabigatran; Echocardiography; Humans; Male; Myocardial Infarction; Myocardial Reperfusion; Thrombosis; Treatment Outcome; Ventricular Dysfunction, Left | 2015 |
Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist.
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; Cost-Benefit Analysis; Dabigatran; Drug Monitoring; Fibrinolytic Agents; Hemorrhage; Humans; Male; Markov Chains; Quality-Adjusted Life Years; Self Care; Stroke; Thrombosis; Vitamin K; Warfarin | 2015 |
Is Thrombin Time useful for the assessment of dabigatran concentrations? An in vitro and ex vivo study.
Topics: Antithrombins; Blood Coagulation; Dabigatran; Drug Monitoring; Humans; In Vitro Techniques; Reproducibility of Results; Sensitivity and Specificity; Thrombin Time; Thrombosis | 2015 |
Acenocoumarol vs. low-dose dabigatran in real-world patients discharged after ischemic stroke.
Topics: Acenocoumarol; Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Brain Ischemia; Dabigatran; Drug Administration Schedule; Female; Humans; Male; Myocardial Infarction; Patient Discharge; Prospective Studies; Stroke; Survival Analysis; Thrombosis | 2016 |
Initial Experience With Novel Oral Anticoagulants During the First 45 Days After Left Atrial Appendage Closure With the Watchman Device.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Appendage; Cardiac Surgical Procedures; Dabigatran; Echocardiography, Transesophageal; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Retrospective Studies; Rivaroxaban; Stroke; Survival Rate; Thrombosis; Treatment Outcome | 2015 |
Dabigatran etexilate versus low-molecular weight heparin to control consumptive coagulopathy secondary to diffuse venous vascular malformations.
Topics: Adult; Anticoagulants; Blood Platelets; Dabigatran; Disseminated Intravascular Coagulation; Enoxaparin; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Platelet Count; Thrombosis; Vascular Malformations | 2016 |
Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism.
Topics: Animals; Anticoagulants; Antithrombins; Dabigatran; Dalteparin; Disease Models, Animal; Disease Progression; Embolization, Therapeutic; Female; Femoral Vein; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Lung; Mice; Mice, Inbred C57BL; Microscopy, Video; Pulmonary Embolism; Thrombosis; Venous Thromboembolism; Venous Thrombosis | 2016 |
Oral anticoagulant therapy and thrombosis. A case of failure of therapy with vitamin K antagonists.
Topics: Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Dyspnea; Echocardiography; Humans; Male; Radiography; Thrombosis; Tomography Scanners, X-Ray Computed; Treatment Failure; Vitamin K | 2016 |
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharm
Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Anticoagulants; Antidotes; Arginine; Consensus; Dabigatran; Evidence-Based Medicine; Factor Xa; Forecasting; Hemorrhage; Humans; Piperazines; Recombinant Proteins; Risk Factors; Thrombosis; Vitamin K | 2017 |
[Successful direct thrombin inhibitor treatment of a left atrial appendage thrombus developed under rivaroxaban therapy].
Topics: Antithrombins; Atrial Appendage; Atrial Fibrillation; Dabigatran; Echocardiography, Transesophageal; Factor Xa Inhibitors; Heart Diseases; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Rivaroxaban; Thrombosis; Treatment Outcome | 2016 |
Laboratory determination of old and new targeted anticoagulant agents for prevention of bleeding and thrombotic events in cancer patients.
Topics: Anticoagulants; Blood Coagulation Tests; Dabigatran; Drug Monitoring; Factor Xa Inhibitors; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Neoplasms; Partial Thromboplastin Time; Pyrazoles; Pyridones; Rivaroxaban; Thrombosis; Warfarin | 2016 |
Concerns about idarucizumab for dabigatran reversal.
Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Blood Coagulation; Clinical Trials, Phase III as Topic; Dabigatran; Humans; Research Design; Thrombosis | 2016 |
Dabigatran Etexilate Reduces Thrombin-Induced Inflammation and Thrombus Formation in Experimental Ischemic Stroke.
Topics: Animals; Anticoagulants; Blood Coagulation; Blood-Brain Barrier; Cerebral Hemorrhage; Dabigatran; Disease Models, Animal; Inflammation; Male; Rats, Wistar; Stroke; Thrombin; Thrombosis | 2016 |
[Substantiation of the system of thrombus formation prevention in treatment of patients with hip joint pathology against the background of arterial insufficiency of the lower extremities].
Topics: Aged; Anticoagulants; Arterial Occlusive Diseases; Arthroplasty, Replacement, Hip; Blood Coagulation; Dabigatran; Enoxaparin; Female; Humans; Lower Extremity; Male; Middle Aged; Osteoarthritis, Hip; Perioperative Care; Postoperative Complications; Retrospective Studies; Risk Adjustment; Russia; Thrombosis | 2016 |
The modification of the thrombin generation test for the clinical assessment of dabigatran etexilate efficiency.
Topics: Antithrombins; Blood Coagulation Tests; Dabigatran; Drug Monitoring; Humans; Thrombosis | 2016 |
Left atrial thrombus under dabigatran in a patient with nonvalvular atrial fibrillation.
Topics: Atrial Fibrillation; Dabigatran; Echocardiography; Heart Atria; Heart Diseases; Humans; Male; Middle Aged; Thrombosis; Treatment Failure | 2016 |
Use of Chronic Oral Anticoagulation and Associated Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Anticoagulants; Atrial Fibrillation; Comorbidity; Dabigatran; Databases, Factual; Female; Hospital Mortality; Humans; Kaplan-Meier Estimate; Length of Stay; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Patient Readmission; Percutaneous Coronary Intervention; Postoperative Hemorrhage; Propensity Score; Proportional Hazards Models; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Stents; Stroke; Thrombosis; Venous Thromboembolism; Warfarin | 2016 |
Dabigatran-related platelet thrombin response during triple anti-thrombotic therapy: A matter of time?
Topics: Aged; Anticoagulants; Antithrombins; Blood Platelets; Dabigatran; Female; Humans; Male; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombin; Thrombosis | 2017 |
The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.
Topics: Administration, Oral; Adult; Anticoagulants; Antiphospholipid Syndrome; Dabigatran; Female; Hemorrhage; Humans; Male; Middle Aged; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Thrombosis; Vitamin K; Young Adult | 2017 |
Changes of in vitro potency of anticoagulant drugs are similar between patients with cirrhosis due to alcohol or non-alcoholic fatty liver disease.
Topics: Adult; Alcoholism; Anticoagulants; Dabigatran; Enoxaparin; Female; Hemostasis; Humans; Liver Cirrhosis; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Pyrazoles; Pyridones; Thrombosis | 2017 |
Improved oral bioavailability and therapeutic efficacy of dabigatran etexilate via Soluplus-TPGS binary mixed micelles system.
Topics: Administration, Oral; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Caco-2 Cells; Dabigatran; Drug Delivery Systems; Fibrinolytic Agents; Humans; Intestinal Absorption; Micelles; Polyethylene Glycols; Polyvinyls; Thrombosis; Vitamin E | 2017 |
Development of Left Atrial Thrombus After Coadministration of Dabigatran Etexilate and Phenytoin.
Topics: Aged; Antithrombins; Cytochrome P-450 CYP1A2 Inducers; Dabigatran; Drug Interactions; Drug Therapy, Combination; Echocardiography, Transesophageal; Heart Atria; Heart Diseases; Humans; Male; Phenytoin; Pulmonary Embolism; Thrombosis | 2017 |
Dabigatran etexilate in a vitamin-K antagonist non responder patient during Heartware HVAD support.
Topics: Aged; Antithrombins; Cardiomyopathy, Dilated; Dabigatran; Female; Follow-Up Studies; Heart-Assist Devices; Humans; Postoperative Care; Thrombosis; Vitamin K | 2017 |
Dabigatran etexilate.
Topics: Anemia; Anticoagulants; Area Under Curve; Benzimidazoles; Dabigatran; Half-Life; Hemorrhage; Humans; Molecular Structure; Platelet Aggregation; Prodrugs; Pyridines; Randomized Controlled Trials as Topic; Suppuration; Surgical Wound Infection; Thromboembolism; Thrombosis; Treatment Outcome | 2008 |
[Always more amputations in Germany?].
Topics: Aged; Amputation, Surgical; Anticoagulants; Arterial Occlusive Diseases; Benzimidazoles; Dabigatran; Fibrinolytic Agents; Germany; Humans; Morpholines; Peripheral Vascular Diseases; Pyridines; Rivaroxaban; Thiophenes; Thrombosis | 2008 |
[New anticoagulants].
Topics: Acute Coronary Syndrome; Anticoagulants; Antithrombins; Benzimidazoles; Dabigatran; Factor Xa Inhibitors; Humans; Morpholines; Pyridines; Rivaroxaban; Thiophenes; Thromboembolism; Thrombosis | 2009 |
Dabigatran etexilate: a new thrombin inhibitor.
Topics: Adult; Benzimidazoles; Dabigatran; Drug Interactions; Humans; Pyridines; Thrombin; Thrombosis | 2010 |
[Anticoagulant therapy in cardiology: yesterday, today, tomorrow].
Topics: Anticoagulants; Benzimidazoles; Carboxypeptidase B2; Cardiovascular Diseases; Clinical Trials, Phase III as Topic; Dabigatran; Fibrinolytic Agents; Humans; Morpholines; Pyridines; Receptor, PAR-1; Rivaroxaban; Thiophenes; Thrombin; Thrombomodulin; Thrombosis; Treatment Outcome; Warfarin | 2010 |
In vitro comparison of dabigatran, unfractionated heparin, and low-molecular-weight heparin in preventing thrombus formation on mechanical heart valves.
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; Blood Coagulation; Dabigatran; Fibrinolytic Agents; Heart Valve Prosthesis; Heparin; Heparin, Low-Molecular-Weight; Humans; Male; Prosthesis Design; Pyridines; Thrombosis; Time Factors | 2010 |
[Direct inhibitors of thrombin, hirudin, bivalirudin, and dabigatran etexilate].
Topics: Anticoagulants; Antithrombins; Benzimidazoles; Contraindications; Dabigatran; Drug Interactions; Heparin; Hirudin Therapy; Hirudins; Humans; Orthopedic Procedures; Peptide Fragments; Postoperative Complications; Pyridines; Recombinant Proteins; Thrombocytopenia; Thrombosis; Venous Thrombosis | 2011 |
Effectiveness of dabigatran etexilate for thromboprophylaxis of mechanical heart valves.
Topics: Administration, Oral; Animals; Anticoagulants; Antithrombins; Aortic Valve; Benzimidazoles; Blood Coagulation; Blood Platelets; Dabigatran; Enoxaparin; Fibrinolytic Agents; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Injections, Subcutaneous; Prosthesis Design; Pyridines; Swine; Thrombelastography; Thrombosis; Time Factors | 2011 |
S35972, a direct-acting thrombin inhibitor with high oral bioavailability and antithrombotic efficacy.
Topics: Administration, Oral; Animals; Anticoagulants; Benzimidazoles; Biological Availability; Blood Coagulation Tests; Dabigatran; Disease Models, Animal; Dogs; Drug Evaluation; Humans; In Vitro Techniques; Inhibitory Concentration 50; Pyrazines; Pyridines; Pyrroles; Rats; Thrombin; Thrombosis | 2011 |
Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatran.
Topics: Aged; Antithrombins; Aphasia; Benzimidazoles; beta-Alanine; Carotid Artery Diseases; Dabigatran; Female; Fracture Fixation; Hemiplegia; Hemorrhage; Humans; Ischemia; Postoperative Complications; Practice Guidelines as Topic; Prosthesis Failure; Risk; Stroke; Thrombolytic Therapy; Thrombosis | 2011 |
A Patient's Guide to Taking Dabigatran Etexilate.
Topics: Anticoagulants; Antithrombin Proteins; Benzimidazoles; Capsules; Dabigatran; Humans; Prodrugs; Pyridines; Thrombosis | 2011 |
Thrombosis on a Mechanical Aortic Valve whilst Anti-coagulated With Dabigatran.
Topics: Aortic Valve; Aortic Valve Stenosis; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Drug Resistance; Echocardiography, Transesophageal; Fibrinolytic Agents; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Intracranial Embolism; Male; Middle Aged; Postoperative Complications; Risk Adjustment; Severity of Illness Index; Thrombosis; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects after oral administration of dabigatran etexilate.
Topics: Administration, Oral; Adult; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Asian People; Atrial Fibrillation; Benzimidazoles; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dabigatran; Female; Humans; Male; Postoperative Complications; Pyridines; Thrombosis; White People | 2012 |
Dabigatran (Pradaxa).
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Dose-Response Relationship, Drug; Hemorrhage; Humans; Thrombosis | 2012 |
Dabigatran versus warfarin after mechanical mitral valve replacement in the swine model.
Topics: Animals; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Evaluation, Preclinical; Female; Heart Valve Prosthesis; Hemorrhage; Male; Mitral Valve; Models, Animal; Sus scrofa; Thrombosis; Warfarin | 2012 |
Dabigatran for stroke prevention in atrial fibrillation.
Topics: Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Evidence-Based Medicine; Humans; Stroke; Thrombosis; Treatment Outcome | 2012 |
Thrombotic events after discontinuing dabigatran: rebound or resumption?
Topics: Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Middle Aged; Recurrence; Thrombosis | 2012 |
Thrombosis of a mechanical heart valve despite dabigatran.
Topics: Aged; Aortic Valve; Benzimidazoles; Dabigatran; Fibrinolytic Agents; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Male; Off-Label Use; Pyridines; Thrombosis; Treatment Failure | 2012 |
Mechanical valve thrombosis with dabigatran.
Topics: Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Diagnosis, Differential; Echocardiography, Transesophageal; Female; Follow-Up Studies; Heart Diseases; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Middle Aged; Prosthesis Failure; Thrombosis | 2012 |
[Introduction].
Topics: Acenocoumarol; Anticoagulants; Benzamides; Benzimidazoles; beta-Alanine; Dabigatran; Heparin; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thromboembolism; Thrombosis; Warfarin | 2012 |
[Percutaneous left atrial appendage closure after resolution of left atrial appendage thrombi with dabigatran].
Topics: Anticoagulants; Antithrombins; Atherectomy; Atrial Appendage; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Comorbidity; Dabigatran; Echocardiography, Transesophageal; Female; Heparin, Low-Molecular-Weight; Humans; Middle Aged; Obesity, Morbid; Risk Factors; Stroke; Thrombosis; Treatment Outcome | 2013 |
Direct thrombin inhibitors.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Antithrombins; Arginine; Benzimidazoles; Blood Coagulation; Dabigatran; Heart Diseases; Heparin; Humans; Pipecolic Acids; Prodrugs; Pyridines; Sulfonamides; Thrombin; Thromboembolism; Thrombosis; Venous Thrombosis | 2005 |
Effects of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate, on thrombus formation and bleeding time in rats.
Topics: Animals; Anticoagulants; Benzimidazoles; Bleeding Time; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Evaluation, Preclinical; Prodrugs; Pyridines; Rats; Thrombosis | 2007 |